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Purpose
To establish the frequency of coronary artery disease in
our KD population and to investigate its correlation
with the time of institution of IV-Ig therapy. In addition
we hope to establish if the time to institution of therapy
is related to delay in diagnosis/referral or timely avail-
ability of IV-Ig supply at our institution.
Methods
Retrospective medical record review of a cohort of
patients with KD over a 10 year period. All patients who
met diagnostic criteria of KD seen in our Institution
between January of 1999 and January of 2009 were
included. The patient population was segregated into two
groups according to the presence or absence of coronary
aneurisms (CA + and CA -). Days from symptom onset
to diagnosis and days from symptom onset to infusion
were recorded. Demographic, clinical, echocardiographic
and laboratory variables were recorded and described as
well. Descriptive statistics and Mann-Whitney Rank Sum
Test for comparison of groups were applied. A p ≤ 0.05
was considered significant.
Results
A hundred eleven patients were enrolled, 92 had com-
plete records. Mean age at onset was 41.3 months. M/F
ratio 1.4. Twenty three patients showed some degree of
cardiac involvement of which 11 (12%) consisted of CA.
The CA + group received first dose of IV-Ig 14,7 +/- 7,2
days from onset of symptoms, while the CA – group
received IV-Ig 10,35 +/- 8,2 days (p= 0,026). For the CA+
group time to diagnosis was 13,7 +/- 7,55 days while it
was 9,6 +/- 7,51 days in the CA - group (p= 0,04). The
time from diagnosis to IV-Ig therapy was similar in the
two groups (p= 0.465) suggesting no supply difficulties at
our institution.
Conclusion
Despite the efficacy of IV-Ig in preventing CA in KD our
frequency of CA remains high at 12%. Delay in institution
of therapy (all patients eventually received IV-Ig therapy)
is the suspected underlying cause. This delay seems to be
related to either access barriers or timely diagnosis. A
referral bias towards more severe cases cannot be ruled
out by the study. Educational efforts to improve index of
suspicion as well as improvement of access are paramount
problems to be addressed by decision makers if the fre-
quency of potentially permanent coronary artery damage
is to be reduced among children with KD in our region.
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